España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Century Therapeutics
IPSC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.33
-0.08
-5.67%
At close: -
$1.41
0.08
6.02%
After Hours: 9:23 AM EDT
Get Report
Comment
Century Therapeutics (IPSC) Forecast
News
Earnings
Century Therapeutics (IPSC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Century Therapeutics (NASDAQ:IPSC) Stock
Century Therapeutics Stock (NASDAQ: IPSC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 07, 2024
Chardan Capital Maintains Buy on Century Ther...
Benzinga Newsdesk
Wednesday, November 06, 2024
HC Wainwright & Co. Maintains Buy on Century ...
Benzinga Newsdesk
Tuesday, November 05, 2024
Century Therapeutics Q3 EPS $(0.37) Beats $(0...
Benzinga Newsdesk
Thursday, October 03, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Thursday, September 26, 2024
Century Therapeutics Tapped Morgan Conn Of Ph...
Benzinga Newsdesk
Thursday, August 15, 2024
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Century ...
Benzinga Newsdesk
Thursday, August 08, 2024
Century Therapeutics Expects Cash Runway Into...
Benzinga Newsdesk
Century Therapeutics Q2 2024 GAAP EPS $(0.38)...
Benzinga Newsdesk
Tuesday, June 18, 2024
Century Therapeutics Files For Shelf Of Up To...
Benzinga Newsdesk
Monday, June 17, 2024
Piper Sandler Maintains Overweight on Century...
Benzinga Newsdesk
Tuesday, June 04, 2024
5 Analysts Assess Century Therapeutics: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Century...
Benzinga Newsdesk
Monday, June 03, 2024
Century Therapeutics Presents Interim Results...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Maintains Buy on Century ...
Benzinga Newsdesk
Century Therapeutics Presents Preclinical Dat...
Benzinga Newsdesk
Thursday, May 09, 2024
Century Therapeutics Q1 2024 GAAP EPS $(0.45)...
Benzinga Newsdesk
Friday, April 12, 2024
Piper Sandler Reiterates Overweight on Centur...
Benzinga Newsdesk
Thursday, April 11, 2024
Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing
Vandana Singh
Century Therapeutics Strengthens Its Autoimmu...
Benzinga Newsdesk
Monday, April 08, 2024
Century Therapeutics Presents New Preclinical...
Benzinga Newsdesk
Friday, March 15, 2024
Canaccord Genuity Maintains Buy on Century Th...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Century...
Benzinga Newsdesk
Thursday, March 14, 2024
Century Therapeutics: Q4 Earnings Insights
Benzinga Insights
Century Therapeutics' 2023 Cash, Cash Equival...
Benzinga Newsdesk
Century Therapeutics FY EPS $(2.30) Misses $(...
Benzinga Newsdesk
Wednesday, March 06, 2024
Century Therapeutics To Present Preclinical D...
Benzinga Newsdesk
Monday, January 22, 2024
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
Faith Ashmore
-
Sponsored
Tuesday, December 19, 2023
Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December
Piero Cingari
Thursday, December 07, 2023
HC Wainwright & Co. Reiterates Buy on Century...
Benzinga Newsdesk
Wednesday, December 06, 2023
Century Therapeutics shares are trading highe...
Benzinga Newsdesk
Century Therapeutics Receives FDA Clearance o...
Benzinga Newsdesk
Monday, November 27, 2023
Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach
Faith Ashmore
-
Sponsored
Thursday, November 09, 2023
Century Therapeutics Q3 EPS $(0.55) Misses $(...
Benzinga Newsdesk
Recap: Century Therapeutics Q3 Earnings
Benzinga Insights
Century Therapeutics And Fujifilm Cellular Dy...
Benzinga Newsdesk
Century Therapeutics Appointed Brent Pfeiffen...
Benzinga Newsdesk
Thursday, November 02, 2023
Century Therapeutics To Present Initial Clini...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 28, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Benzinga Insights
Workday To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday
Lisa Levin
JP Morgan Downgrades Century Therapeutics to ...
Benzinga Newsdesk
Thursday, August 10, 2023
Piper Sandler Maintains Overweight on Century...
Benzinga Newsdesk
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
These Analysts Slash Their Forecasts On Century Therapeutics After Weak Q2 Results
Lisa Levin
HC Wainwright & Co. Maintains Buy on Century ...
Benzinga Newsdesk
EF Hutton Reiterates Buy on Century Therapeut...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Century Ther...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch